YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also manufactures and sells active pharmaceutical ingredients; researches and develops medical devices and drugs, as well as biotechnology; and provides medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. It has a strategic cooperation framework agreement with Alibaba Health Technology (China) Limited to carry out influenza special projects; Jointown Pharmaceutical Group Co., Ltd.; Guangdong Yihao Pharmaceutical Co., Ltd.; and Shenzhen HEC Industrial Development Co., Ltd, as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a subsidiary of Guangdong HEC Technology Holding Co., Ltd.
YiChang HEC ChangJiang Pharmaceutical Dividend Announcement
• YiChang HEC ChangJiang Pharmaceutical announced a semi annually dividend of HK$0.11 per ordinary share which will be made payable on 2020-11-16. Ex dividend date: 2020-09-29
• YiChang HEC ChangJiang Pharmaceutical's trailing twelve-month (TTM) dividend yield is -%
YiChang HEC ChangJiang Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2020-09-29 | HK$0.11 | semi annually | 2020-11-16 |
2020-06-09 | HK$0.33 | semi annually | 2020-07-10 |
2019-10-15 | HK$1.11 | semi annually | 2019-11-15 |
2019-06-11 | HK$0.68 | semi annually | 2019-07-19 |
2018-10-22 | HK$0.45 | semi annually | 2018-11-15 |
2018-06-12 | HK$0.37 | semi annually | 2018-07-16 |
2017-10-17 | HK$0.40 | semi annually | 2017-11-10 |
2017-06-20 | HK$0.34 | semi annually | 2017-07-14 |
2016-06-08 | HK$0.18 | semi annually | 2016-07-15 |
YiChang HEC ChangJiang Pharmaceutical Dividend per year
YiChang HEC ChangJiang Pharmaceutical Dividend growth
YiChang HEC ChangJiang Pharmaceutical Dividend Yield
YiChang HEC ChangJiang Pharmaceutical current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing YiChang HEC ChangJiang Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
YiChang HEC ChangJiang Pharmaceutical Financial Ratios
YiChang HEC ChangJiang Pharmaceutical Dividend FAQ
Other factors to consider when evaluating YiChang HEC ChangJiang Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy YiChang HEC ChangJiang Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: YiChang HEC ChangJiang Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, YiChang HEC ChangJiang Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, YiChang HEC ChangJiang Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from YiChang HEC ChangJiang Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: YiChang HEC ChangJiang Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, YiChang HEC ChangJiang Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: YiChang HEC ChangJiang Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of YiChang HEC ChangJiang Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review YiChang HEC ChangJiang Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.